CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change · Shell status change
- SC 14F1/A Other SC 14F1/A
- SC 14F1 Other SC 14F1
- 8-K Event Auditor change
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 5 Insider Annual Insider Trading Report
- 10-Q/A Report 10-Q/A
- 10-K Report Annual Report
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
Page 63 of 65 · 1,286 filings